Clinical Trial Update: The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adalimumab plus methotrexate versus placebo plus methotrexate in rheumatoid arthritis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED